PERINATOLOGIYA I PEDIATRIYA.2015.3(63):51-54; doi 10.15574/PP.2015.63.51 
 

Vaccination: myths and facts (review of literature) 
 

Oniskova O. V.

Vinnytsia National Pyrogov Memorial Medical University, Vinnytsia, Ukraine 
 

Antyvaktsynatorstvo in Ukraine is extremely urgent problem, because the purpose of scientific research to establish the main causes of failures of vaccination and provide facts which they deny. 
 

Patients and methods. A survey of 225 parents of children 2010 and 2011 was born three stations Vinnytsia, during which identified the main causes of failures of vaccination. 
 

Research results have proved relying on known scientific facts. All of the reasons for our failures of varying immunization vaccine is scientifically unfounded and baseless. 
 

Conclusions. Detailed analysis of the causes of failures of vaccination and proof of the necessity and appropriateness of vaccinations will cover more mass vaccination of the population and protect a large number of people from serious infectious diseases. 
 

Key words: vaccination, children, the causes of failures. 
 

REFERENCES

1. Туберкульоз в Україні (Аналітично-статистичний довідник за 2001—2012 роки). Київ. 2013: 122.

2. Simons E, Ferrari M, Fricks J et al. 2012. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 379;9832: 2173—2178. http://dx.doi.org/10.1016/S0140-6736(12)60522-4

3. Barreto ML, Pereira SM, Ferreira AA. 2006. BCG vaccine: efficacy and indications for vaccination and revaccination. J Pediatr (Rio J). 83; Suppl 3: 45—54. http://dx.doi.org/10.2223/JPED.1499; PMid:16826312

4. Hviid A, Wohlfahrt J, Stellfeld M, Melbye M. 2005. Childhood vaccination and nontargeted infectious disease hospitalization. JAMA. 294;6: 699—705. http://dx.doi.org/10.1001/jama.294.6.699; PMid:16091572

5. Thompson WW, Price C, Goodson B et al. 2007. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 357;13: 1281—1292. http://dx.doi.org/10.1056/NEJMoa071434; PMid:17898097

6. Roy A, Eisenhut M, Harris RJ et al. 2014. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. 349: 1—11. http://dx.doi.org/10.1136/bmj.g4643; PMid:25097193 PMCid:PMC4122754

7. Soysal A, Millington KA, Bakir M et al. 2005. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet. 366;9494: 1443—1451. http://dx.doi.org/10.1016/S0140-6736(05)67534-4

8. Duclos P, Okwo-Bele JM, Gacic-Dobo M, Cherian T. 2009. Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights. 9; Suppl 1: S2: 1—11.

9. Hamzaoui A. 2015. Childhood tuberculosis. Rev Pneumol Clin. 71;2—3: 168—180.

10. Shepard CW, Simard EP, Finelli L. 2006. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 28;1: 112—125. http://dx.doi.org/10.1093/epirev/mxj009; PMid:16754644

11. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine — Worldwide, 2013—2016. Immunization Systems Management Group of the Global Polio Eradication Initiative. MMWR Morb Mortal Wykly Rep. 2015. 64;25: 699-702. PMid:26135591

12. Sorup S, Benn CS, Poulsen A et al. 2014. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA. 311;8: 826—835. http://dx.doi.org/10.1001/jama.2014.470; PMid:24570246

13. Zanetti AR, Mariano A, Romano L et al. 2005. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 366; 9494: 1379—1384. http://dx.doi.org/10.1016/S0140-6736(05)67568-X

14. Madalinski K, Kolakowska A, Godzik P. 2015. Current views on the persistence of immunity following hepatitis B vaccination. Przegl Epidemiol. 69;1: 147—150.

15. Matheson AJ, Goa KL. 2000. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection. Paediatr Drugs. 2;2: 139—159. http://dx.doi.org/10.2165/00128072-200002020-00007; http://dx.doi.org/10.2165/00148581-200002020-00007; PMid:10937466

16. McCormack PL. 2012. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix^®): a review of its properties and use as a single_dose booster immunization. Drugs. 72;13: 1765—1791. http://dx.doi.org/10.2165/11209630-000000000-00000; PMid:22931522

17. Mrozek-Budzyn D, Kieltyka A, Majewska R, Augustyniak M. 2013. Measles, mumps and rubella (MMR) vaccination has no effect on cognitive development in children — the results of the Polish prospective cohort study. Vaccine. 31;22: 2551—2557. http://dx.doi.org/10.1016/j.vaccine.2013.03.057; PMid:23588083 PMCid:PMC3684783

18. Mrozek-Budzyn D, Majewska R, Kieltyka A. 2015. Early exposure to thimerosal-containing vaccines and children's cognitive development. A 9-year prospective birth cohort study in Poland. Eur J Pediatr. 174;3: 383—391. http://dx.doi.org/10.1007/s00431-014-2412-5; PMid:25185528 PMCid:PMC4334107

19. Mrozek-Budzyn D, Kieltyka A, Majewska R. 2010. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Pediatr Infect Dis J. 29;5: 397—400. http://dx.doi.org/10.1097/INF.0b013e3181c40a8a; PMid:19952979

20. Price CS, Thompson WW, Goodson B et al. 2010. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 126;4: 656—664. http://dx.doi.org/10.1542/peds.2010-0309; PMid:20837594

21. Mangtani P, Abubakar I, Ariti C et al. 2014. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. 58;4: 470—480.

22. Roush SW, Murphy TV. 2007. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. Vaccine-Preventable Disease Table Working Group. JAMA. 298;18: 2155—2163. http://dx.doi.org/10.1001/jama.298.18.2155; PMid:18000199

23. Scott LJ, McCormack PL. 2013. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix^®): a guide to its use as a single-dose booster immunization against pertussis. BioDrugs. 72;1: 75—81. http://dx.doi.org/10.1007/s40259-012-0009-y; PMid:23329401

24. Abubakar, Pimpin L, Ariti C et al. 2013. Systematic review and meta_analysis of the current evidence on the duration of protection by bacillus Calmette_Guerin vaccination against tuberculosis. 17;37: 1—372.

25. Vildozola H. 2007. Vaccination against Hepatitis B: 20 years later. Rev Gastroenterol Peru. 27;1: 57—66. PMid:17431429